Literature DB >> 17350179

Anti-TB activity of Evodia elleryana bark extract.

Louis R Barrows1, Emma Powan, Christopher D Pond, Teatulohi Matainaho.   

Abstract

An ethyl acetate extract of bark from Evodia elleryana produced significant growth inhibition of Mycobacterium tuberculosis at concentrations only minimally inhibitory to human T cells. The crude extract yielded 95% inhibition of TB at 50 microg/ml. The crude extract yielded 29% growth inhibition of human T-cells in culture at that concentration.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17350179      PMCID： PMC2754760          DOI： 10.1016/j.fitote.2006.12.001

Source DB:  PubMed          Journal:  Fitoterapia        ISSN： 0367-326X            Impact factor:   2.882


  7 in total

1.  Antimicrobial activity of Evodia elleryana.

Authors:  M R Khan; M Kihara; A D Omoloso
Journal:  Fitoterapia       Date:  2000-02       Impact factor: 2.882

2.  Quinolone alkaloids from Evodia rutaecarpa: a potent new group of antimycobacterial compounds.

Authors:  Michael Adams; Abraham Abebe Wube; Franz Bucar; Rudolf Bauer; Olaf Kunert; Ernst Haslinger
Journal:  Int J Antimicrob Agents       Date:  2005-09       Impact factor: 5.283

3.  Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay.

Authors:  S G Franzblau; R S Witzig; J C McLaughlin; P Torres; G Madico; A Hernandez; M T Degnan; M B Cook; V K Quenzer; R M Ferguson; R H Gilman
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

4.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors:  T Mosmann
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

5.  Highly selective antibacterial activity of novel alkyl quinolone alkaloids from a Chinese herbal medicine, Gosyuyu (Wu-Chu-Yu), against Helicobacter pylori in vitro.

Authors:  N Hamasaki; E Ishii; K Tominaga; Y Tezuka; T Nagaoka; S Kadota; T Kuroki; I Yano
Journal:  Microbiol Immunol       Date:  2000       Impact factor: 1.955

6.  Rapid and simple MTT method for rifampicin and isoniazid susceptibility testing of Mycobacterium tuberculosis.

Authors:  S Foongladda; D Roengsanthia; W Arjrattanakool; C Chuchottaworn; A Chaiprasert; S G Franzblau
Journal:  Int J Tuberc Lung Dis       Date:  2002-12       Impact factor: 2.373

7.  The anti-neoplastic and novel topoisomerase II-mediated cytotoxicity of neoamphimedine, a marine pyridoacridine.

Authors:  Kathryn M Marshall; Sandra S Matsumoto; Joseph A Holden; Gisela P Concepción; Deniz Tasdemir; Chris M Ireland; Louis R Barrows
Journal:  Biochem Pharmacol       Date:  2003-08-01       Impact factor: 5.858
  7 in total
  2 in total

1.  Making the most of Papua New Guinea's biodiversity: Establishment of an integrated set of programs that link botanical survey with pharmacological assessment in "The Land of the Unexpected"

Authors:  L R Barrows; T K Matainaho; C M Ireland; S Miller; G T Carter; T Bugni; P Rai; O Gideon; B Manoka; P Piskaut; R Banka; R Kiapranis; J N Noro; C D Pond; C D Andjelic; M Koch; M K Harper; E Powan; A R Pole; J B Jensen
Journal:  Pharm Biol       Date:  2009-08-01       Impact factor: 3.503

2.  Anti-inflammatory and anti-infectious effects of Evodia rutaecarpa (Wuzhuyu) and its major bioactive components.

Authors:  Jyh-Fei Liao; Wen-Fei Chiou; Yuh-Chiang Shen; Guei-Jane Wang; Chieh-Fu Chen
Journal:  Chin Med       Date:  2011-02-14       Impact factor: 5.455
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.